Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05754008 · ClinicalTrials.gov registry record · NA

Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
204
Enrollment target
1
Study location

NCT05754008 is a NA study of Diabetes Mellitus, Type 2 that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 204 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05754008, a NA study of Diabetes Mellitus, Type 2, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
204 participants
Enrollment target
1
Study location

Study Summary

The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).

Conditions Studied

Interventions

  • BEHAVIORAL AURORA Care Strategy

Study Locations (1)

California

  • Kaiser Permanente Northern California - Oakland

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2023-03-31
Est. Completion 2025-12
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05754008

The ClinicalTrials.gov registry entry for NCT05754008 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which AURORA Care Strategy is the first listed.

NCT05754008 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05754008 about?

NCT05754008 is a clinical study titled "Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes". The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).

What is the current status of trial NCT05754008?

This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2023-03-31. Estimated completion is 2025-12.

What conditions does trial NCT05754008 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT05754008?

The interventions under investigation include: AURORA Care Strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05754008?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05754008 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.